Regular Article
Redox Control of Aryl Sulfotransferase Specificity

https://doi.org/10.1006/abbi.2000.2020Get rights and content

Abstract

Aryl sulfotransferase IV from rat liver has the very broad substrate range that is characteristic of the enzymes of detoxication. With the conventional assay substrates, 4-nitrophenol and PAPS, sulfation was considered optimal at pH 5.5 whereas the enzyme in the physiological pH range was curiously ineffective. These properties would seem to preclude a physiological function for this cytosolic enzyme. Partial oxidation of the enzyme, however, results not only in a substantial increase in the rate of sulfation of 4-nitrophenol at physiological pH but also in a shift of the pH optimum to this range and radically altered overall substrate specificity. The mechanism for this dependence on redox environment involves oxidation at Cys66, a process previously shown to occur by formation of a mixed disulfide with glutathione or by the formation of an internal disulfide with Cys232. Oxidation at Cys66 acts only as a molecular redox switch and is not directly part of the catalytic mechanism. Underlying the activation process is a change in the nature of the ternary complex formed between enzyme, phenol, and the reaction product, adenosine 3′,5′-bisphosphate. The reduced enzyme gives rise to an inhibitory, dead-end ternary complex, the stability of which is dictated by the ionization of the specific phenol substrate. Ternary complex formation impedes the binding of PAPS that is necessary to initiate a further round of the reaction and is manifest as profound, substrate-dependent inhibition. In contrast, the ternary complex formed when the enzyme is in the partially oxidized state allows binding of PAPS and the unhindered completion of the reaction cycle.

References (36)

  • Y. Kakuta et al.

    J. Biol. Chem.

    (1999)
  • L.M. Bidwell et al.

    J. Mol. Biol.

    (1999)
  • R. Dajani et al.

    J. Biol. Chem.

    (1999)
  • R.D. Sekura et al.

    Arch. Biochem. Biophys.

    (1981)
  • Y.-S. Yang et al.

    Protein Expr. Purif.

    (1996)
  • A.D. Marshall et al.

    J. Biol. Chem.

    (1997)
  • Y. Zheng et al.

    J. Biol. Chem.

    (1994)
  • X. Chen et al.

    Protein Expr. Purif.

    (1992)
  • W.-X.A. Guo et al.

    Chem. Biol. Interact.

    (1994)
  • S.G. Ramaswamy et al.

    J. Biol. Chem.

    (1987)
  • J.N. Ketley et al.

    J. Biol. Chem.

    (1975)
  • M.W. Duffel et al.

    J. Biol. Chem.

    (1981)
  • W.B. Jakoby et al.

    J. Biol. Chem.

    (1990)
  • H. Zhang et al.

    J. Biol. Chem.

    (1998)
  • A.D. Marshall et al.

    Chem. Biol. Interact.

    (1998)
  • S. Ramaswamy et al.

    J. Biol. Chem.

    (1987)
  • K.E. Neet et al.

    Methods Enzymol.

    (1980)
  • Cited by (35)

    • Sulfotransferases

      2018, Comprehensive Toxicology: Third Edition
    • Substrate inhibition in human hydroxysteroid sulfotransferase SULT2A1: Studies on the formation of catalytically non-productive enzyme complexes

      2011, Archives of Biochemistry and Biophysics
      Citation Excerpt :

      Studies on the catalytic mechanism of cytosolic sulfotransferases have been primarily focused on the SULT1 family (previously known as either as phenol or aryl sulfotransferases). Kinetic and crystallographic studies on these enzymes have elucidated several general principles regarding the chemical mechanism of sulfuryl transfer from PAPS to an acceptor substrate [1,24–31], that, based on three-dimensional structural homologies, may be applicable to members of other SULT families. Details of the kinetic mechanisms for individual SULTs, however, continue to provide information on the substrate-dependent differences in sulfation reactions that define the specificities and functions of these enzymes.

    • Physicochemical properties of hydroxylated polychlorinated biphenyls aid in predicting their interactions with rat sulfotransferase 1A1 (rSULT1A1)

      2011, Chemico-Biological Interactions
      Citation Excerpt :

      This substrate inhibition is due to the formation of dead end complexes between the substrate, enzyme and the co-product of sulfation, adenosine-3′,5′-diphosphate (PAP) [26,27]. The release of PAP from these dead-end complexes becomes a rate-limiting component of the rSULT1A1-catalyzed reaction [27], and changes in the conformation at the PAP/PAPS-binding site of the enzyme may affect catalytic function and inhibition through facilitation of PAP-release [2,27]. Thus the present studies are focused on molecular characteristics of OHPCB-substrates that influence the rate of reaction, the use of calculated estimates of physicochemical parameters in the prediction of interactions of OHPCBs as substrates and inhibitors, and the potential role of the redox status of the enzyme in determining its binding interactions with OHPCBs and PAP.

    • Sulfotransferases

      2010, Comprehensive Toxicology, Second Edition
    View all citing articles on Scopus
    1

    Present address: Novartis Institute for Medical Sciences, 5 Gower Place, London WC1E 6BN, UK.

    2

    To whom correspondence should be addressed at the National Institutes of Health, Building 8, Room 311, Bethesda, MD 20892. Fax: (301) 480-0040. E-mail: [email protected].

    View full text